Singular Genomics Systems, Inc. (OMIC) NASDAQ

Currency In USD

AD

Valuation

Market Cap33.49M
Enterprise Value92.54M
P/E Ratio-0.51
PEG Ratio-0.09
Price/Sales Ratio17.44
Price/Book Ratio0.27
Enterprise/Revenue37.73
Enterprise/EBITDA-1.27

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-32.57
Operating Margin-35.31
AD

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.43

Income Statement

Revenue2.91M
Revenue/Share1.2
Gross Profit-558,000
EBITDA-86.5M
Net Income-94.82M
Diluted EPS-39.08

Balance Sheet

Total Cash113.83M
Total Cash/Share71.68
Total Debt50.49M
Total Debt/Equity0.42
Current Ratio10.51
Book Value Per Share73.77

Price History

52-Week Change29.51
52-Week High23.41
52-Week Low5.34
Moving Average 50 Days19.81
Moving Average 200 Days14.23

Statistics

Average Volume13,411
Shares Outstanding2.54M
% Held by Institutions44.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateJune 26, 2024
AD